CYDY could have cherry picked some of the patients
Post# of 148169
(Total Views: 1056)
Posted On: 08/02/2020 8:09:57 AM
CYDY could have cherry picked some of the patients and released it like Humanigen did with 12 on lenzilumab.
Instead we got a confusing press release without any real clear markers.
The struggle is real and this post stolen from gg100 at the IV biotech2k board says it all in a fun and slapstick sort of way...
<<I find the CYDY story so entertaining because of all the eclectic and improbable characters and events. The whole CYDY for covid thing is preposterous on its face, but then it happens.
My favorite comment is from the CEO on April 27:
...leronlimab, we were not on the map (for Covid19). Nobody thought we were on the map (for Covid19) and we didn't know either. Dr. Patterson and Dr. Scott Kelly had talked about it and then when Dr. Harish Seethamraju from Montefiore Medical Center heroically came and said "I need this" that started everything. Thank God for that...
They had no idea they were on the map!
And then Patterson suddenly chimes in with, "RANTES is the problem and leronlimab is the answer." If the script was submitted to Hollywood for review, it would be immediately dismissed as too fanciful.
Its like this ragtag bunch of characters is suddenly thrust into the strongest spotlight that has ever shined on biotech.
And now suddenly the obscure, off-the-map biotech with all of its oddball idiosyncracies is on full display for everyone to see.
The whole thing is so much like Forrest Gump. He is thrust into the situation without any prior experience, without any knowledge of how anything works, without any idea of how hard it might be, but he just keeps going and focuses on the next step he is about to take. And he enjoys chatting with anyone and everyone about each step as he goes. Certainly a fine way to conduct your business if you can make it work. I find it tremendously entertaining and refreshing. But this is investing and Forrest Gump was a fantasy. Right?>>
Instead we got a confusing press release without any real clear markers.
The struggle is real and this post stolen from gg100 at the IV biotech2k board says it all in a fun and slapstick sort of way...
<<I find the CYDY story so entertaining because of all the eclectic and improbable characters and events. The whole CYDY for covid thing is preposterous on its face, but then it happens.
My favorite comment is from the CEO on April 27:
...leronlimab, we were not on the map (for Covid19). Nobody thought we were on the map (for Covid19) and we didn't know either. Dr. Patterson and Dr. Scott Kelly had talked about it and then when Dr. Harish Seethamraju from Montefiore Medical Center heroically came and said "I need this" that started everything. Thank God for that...
They had no idea they were on the map!
And then Patterson suddenly chimes in with, "RANTES is the problem and leronlimab is the answer." If the script was submitted to Hollywood for review, it would be immediately dismissed as too fanciful.
Its like this ragtag bunch of characters is suddenly thrust into the strongest spotlight that has ever shined on biotech.
And now suddenly the obscure, off-the-map biotech with all of its oddball idiosyncracies is on full display for everyone to see.
The whole thing is so much like Forrest Gump. He is thrust into the situation without any prior experience, without any knowledge of how anything works, without any idea of how hard it might be, but he just keeps going and focuses on the next step he is about to take. And he enjoys chatting with anyone and everyone about each step as he goes. Certainly a fine way to conduct your business if you can make it work. I find it tremendously entertaining and refreshing. But this is investing and Forrest Gump was a fantasy. Right?>>
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼